ACOM - Advanced Center Oncology Macerata

ACOM – Advanced Center Oncology Macerata is a private Italian pharmaceutical company founded in 1999 specializing in the research, development, and manufacture of diagnostic radiopharmaceuticals for oncology applications. Its lead product is copper (^64Cu) chloride for PET imaging as a contrast agent, which has been approved in the EU since August 2012. Another pipeline asset is ^124I-DIATHIS‑1 targeting neoplasms with pending approval status. The company operates from its headquarters and GMP facility in Montecosaro, Italy, employs approximately a dozen staff members, sponsors orphan designations within Europe, and focuses on innovative solutions to improve cancer diagnostics through advanced nuclear medicine technologies.